Can a phone app stop suicide? new trial aims to find out

NCT ID NCT07160465

Not yet recruiting Symptom relief Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether a smartphone app called emma, used alongside the standard VigilanS program, can reduce suicide events (like attempts or hospital visits) in adults who recently attempted suicide. The app lets users quickly contact crisis support, tracks mood, and offers coping tools. Researchers will follow 632 participants for 6 months to see if the app makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: emma smartphone application
What this could lead to: If it works, this app could provide real-time support and risk detection for people at high risk of suicide, potentially reducing suicide attempts and deaths.
What could go wrong: This is an early-stage trial with no prior efficacy data. The app relies on self-reporting and smartphone access, which may not suit everyone. Results may not generalize beyond the French healthcare system.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicide Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUICIDE SUICIDE ATTEMPT

Contacts and locations

Locations

University hospital

Montpellier, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.